about
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsInflammatory cytokines and neurological and neurocognitive alterations in the course of schizophreniaComparison of peripheral and central schizophrenia biomarker profilesMeta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effectsTranscriptome sequencing of the choroid plexus in schizophreniaBehavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Viral infection, inflammation and schizophreniaThe Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.Common variants on Xq28 conferring risk of schizophrenia in Han Chinese.Excess of homozygosity in the major histocompatibility complex in schizophrenia.Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.Possible association between interleukin-1β gene and schizophrenia in a Japanese population.Genetics in schizophrenia: where are we and what next?Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.DNA methylation differences in monozygotic twin pairs discordant for schizophrenia identifies psychosis related genes and networks.Immune aging, dysmetabolism, and inflammation in neurological diseases.Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes.Is there a role for immune-to-brain communication in schizophrenia?Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia.Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphanThe proteome of schizophrenia.Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.Is it time for immunopsychiatry in psychotic disorders?Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.Chronic Antipsychotic Treatment in the Rat - Effects on Brain Interleukin-8 and Kynurenic Acid.Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidineElevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.Imbalanced kynurenine pathway in schizophrenia.Imaging the role of inflammation in mood and anxiety-related disorders.
P2860
Q24623659-5430A5E3-B8DC-4DA3-9E94-421F230BC761Q24630651-7FBE3B44-D587-47AD-86F8-CDB51C1DAAD3Q28484626-662DA9D1-A9AC-405B-A47C-09CDB51EE5A2Q28657600-C1887D5B-9E6A-4298-9129-5604B9FC14BFQ30363952-1EC5BA82-9C7F-4A2D-8427-350652E975C0Q30419650-6F06F7F1-D374-42FF-8E5F-7DB8A9E9A6A1Q30440507-A061ECD7-5BBF-4AE9-98D0-B84FB5B0ECBEQ33451672-1E66310D-9196-40ED-B16D-B5ADB6C7747CQ33453744-D6A9BBDD-9743-4F15-8E2A-24008EED6743Q33601896-51898BBA-B71E-4495-9C92-CC5A0F79F13AQ33707711-BA04C47E-5A23-461B-90F4-99581EC74569Q33762506-01E34979-023B-4E79-B345-15EAD4C15829Q34379000-4398F00B-388D-4266-B25E-1C5DABFD96FAQ35162796-A68B07F9-4D51-43F9-83F1-3DB4842D39C4Q35200533-52958F59-4DCD-4C6C-83DC-043E0829F8CDQ35237268-66EDF78A-4115-440B-88EF-392023537C95Q35603078-DB7EB778-3222-4A02-999A-91280F5FBE55Q35622570-FEF10221-4BC1-4FC2-B388-728AD108AFF9Q35677347-C15ADFF2-65E7-4BBE-87AB-99B383D03D05Q35909867-B60BD070-B83A-44A1-9BEF-1E8E1A697E74Q36351021-5D190C36-147A-48D7-B1E6-17905032B53DQ36712400-E68066E7-38FA-4F18-A5C2-CFAAA48101C8Q36725461-BA2EF42F-F36B-4305-8AA3-4DB26A27AC76Q36848272-06964D2B-3BB7-4950-9EBA-B42142624FBAQ36924599-1F787F23-6E5E-4FE3-9700-E165E147943BQ36998471-46E06CD3-009B-43B2-8340-0029EEF60466Q37136385-48A7F5F4-8ABE-4DA9-AA7D-66943AE0F47AQ37186953-D6F3588A-B664-449E-908D-4C506B9614D6Q38170139-364F68B9-1C0D-4177-B4E0-F3B466BCF7E8Q38779149-102C820A-497F-41F1-AC3C-D99795325786Q38915253-667F44BC-6E62-420F-91CE-8C9E141F6D56Q39050960-FCA53567-48A6-485E-9E58-9001C652D267Q39777451-ECAA8681-424B-4442-80F9-5E5D42BD10A7Q40452897-75C1018D-B72F-483C-8E1A-9E7F699B0110Q40965410-E0B0DA73-A407-40E0-968F-457491095AD0Q41771344-90E446EA-B330-4C01-87F4-B451AE6A9981Q42375259-065E087A-5B6F-4F86-81E9-9290C4B7BA29Q42628955-21E27E41-0623-4479-A7C3-8B80F039CF6CQ42921229-FBE655B5-1D84-445A-9686-E64A498577A0Q47305318-2D9D4C9F-67D6-4EB6-8E1D-4771BB6136BC
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Activation of brain interleukin-1beta in schizophrenia.
@en
Activation of brain interleukin-1beta in schizophrenia.
@nl
type
label
Activation of brain interleukin-1beta in schizophrenia.
@en
Activation of brain interleukin-1beta in schizophrenia.
@nl
prefLabel
Activation of brain interleukin-1beta in schizophrenia.
@en
Activation of brain interleukin-1beta in schizophrenia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Activation of brain interleukin-1beta in schizophrenia
@en
P2093
P2860
P2888
P304
P356
10.1038/MP.2009.52
P407
P577
2009-12-01T00:00:00Z